Group One Trading’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.41M Sell
21,800
-2,100
-9% -$148K ﹤0.01% 2406
2025
Q4
$1.61M Sell
23,900
-20,600
-46% -$1.39M ﹤0.01% 2469
2025
Q3
$3.26M Sell
44,500
-20,900
-32% -$1.39M 0.01% 1871
2025
Q2
$3.4M Buy
65,400
+13,500
+26% +$768K 0.01% 1640
2025
Q1
$3.31M Sell
51,900
-11,000
-17% -$639K 0.01% 1393
2024
Q4
$3.01M Buy
62,900
+3,500
+6% +$179K 0.01% 1568
2024
Q3
$3.4M Buy
59,400
+7,200
+14% +$413K 0.01% 1311
2024
Q2
$2.73M Buy
52,200
+8,300
+19% +$364K 0.01% 1210
2024
Q1
$1.79M Sell
43,900
-6,600
-13% -$247K 0.01% 1576
2023
Q4
$1.87M Buy
50,500
+4,100
+9% +$154K ﹤0.01% 1934
2023
Q3
$1.77M Sell
46,400
-600
-1% -$24.6K 0.01% 1739
2023
Q2
$1.7M Sell
47,000
-42,400
-47% -$1.45M 0.01% 1871
2023
Q1
$3.41M Sell
89,400
-47,900
-35% -$2.25M 0.01% 1096
2022
Q4
$7.81M Buy
137,300
+73,800
+116% +$3.78M 0.02% 878
2022
Q3
$2.51M Buy
63,500
+5,700
+10% +$252K ﹤0.01% 1708
2022
Q2
$2.54M Buy
57,800
+30,200
+109% +$1.31M ﹤0.01% 1838
2022
Q1
$1.1M Sell
27,600
-142,800
-84% -$5.09M ﹤0.01% 2982
2021
Q4
$6.85M Buy
170,400
+40,200
+31% +$1.5M 0.01% 1423
2021
Q3
$5.3M Sell
130,200
-22,000
-14% -$920K 0.01% 1625
2021
Q2
$6.91M Buy
152,200
+23,000
+18% +$1.02M 0.01% 1395
2021
Q1
$5.39M Buy
129,200
+1,500
+1% +$68.5K 0.01% 1454
2020
Q4
$5.45M Buy
127,700
+33,500
+36% +$1.2M 0.01% 1205
2020
Q3
$2.48M Sell
94,200
-151,800
-62% -$4.23M 0.01% 1433
2020
Q2
$6.59M Buy
246,000
+144,900
+143% +$3.27M 0.03% 634
2020
Q1
$1.82M Sell
101,100
-79,600
-44% -$1.51M 0.01% 1107
2019
Q4
$3.2M Buy
180,700
+62,200
+52% +$1.08M 0.02% 948
2019
Q3
$1.84M Sell
118,500
-73,100
-38% -$1.2M 0.01% 1269
2019
Q2
$3.29M Sell
191,600
-39,400
-17% -$636K 0.03% 761
2019
Q1
$3.72M Sell
231,000
-25,900
-10% -$420K 0.04% 581
2018
Q4
$3.76M Buy
256,900
+92,300
+56% +$1.47M 0.03% 643
2018
Q3
$2.99M Buy
164,600
+8,500
+5% +$149K 0.02% 880
2018
Q2
$2.63M Sell
156,100
-82,300
-35% -$1.56M 0.02% 933
2018
Q1
$4.67M Sell
238,400
-224,500
-48% -$4.35M 0.05% 505
2017
Q4
$9.38M Buy
462,900
+66,100
+17% +$1.22M 0.07% 365
2017
Q3
$6.89M Buy
396,800
+79,300
+25% +$1.07M 0.06% 388
2017
Q2
$4.07M Buy
317,500
+122,100
+62% +$1.63M 0.04% 558
2017
Q1
$2.53M Sell
195,400
-29,100
-13% -$368K 0.03% 722
2016
Q4
$2.22M Buy
224,500
+88,100
+65% +$965K 0.02% 864
2016
Q3
$1.65M Buy
136,400
+23,100
+20% +$236K 0.02% 955
2016
Q2
$978K Buy
113,300
+20,700
+22% +$204K 0.01% 1279
2016
Q1
$877K Sell
92,600
-95,000
-51% -$894K 0.01% 1276
2015
Q4
$3.25M Sell
187,600
-29,900
-14% -$477K 0.04% 578
2015
Q3
$2.92M Sell
217,500
-46,000
-17% -$924K 0.04% 584
2015
Q2
$5.95M Buy
263,500
+68,400
+35% +$1.2M 0.08% 259
2015
Q1
$2.79M Sell
195,100
-9,400
-5% -$136K 0.04% 480
2014
Q4
$1.97M Sell
204,500
-68,900
-25% -$612K 0.03% 648
2014
Q3
$2.49M Buy
273,400
+57,100
+26% +$544K 0.04% 585
2014
Q2
$2.14M Buy
216,300
+17,600
+9% +$149K 0.03% 652
2014
Q1
$2.52M Sell
198,700
-20,900
-10% -$310K 0.04% 516
2013
Q4
$3.29M Buy
219,600
+55,300
+34% +$711K 0.05% 395
2013
Q3
$1.81M Sell
164,300
-67,100
-29% -$559K 0.03% 619
2013
Q2
$1.84M Buy
+231,400
New +$1.47M 0.05% 463

Other funds holding HALO

Group One Trading's HALO Position: Q4 2024 in Review

Group One Trading sold out of Halozyme (HALO) in Q4 2024, closing a stake of 9,855 shares — an estimated $505K sold.

Group One Trading first reported a position in HALO in Q2 2013 and held it in 22 quarters. The position peaked at $3.07M in Q4 2013. 508 funds tracked by Wall St. Rank hold HALO as of Q4 2024.

  • Group One Trading reported no remaining Halozyme position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 9,855 Halozyme shares in Q4 2024, an estimated $505K.
  • Group One Trading first reported a position in Halozyme in Q2 2013 and held it in 22 quarters.
  • Group One Trading's Halozyme position peaked at $3.07M in Q4 2013.
  • 508 funds tracked by Wall St. Rank held Halozyme as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.